SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-22-123589
Filing Date
2022-04-27
Accepted
2022-04-27 16:05:53
Documents
8
Period of Report
2022-06-17

Document Format Files

Seq Description Document Type Size
1 DEF 14A d312302ddef14a.htm DEF 14A 342698
2 GRAPHIC g312302dsp039a.jpg GRAPHIC 2950
3 GRAPHIC g312302dsp039b.jpg GRAPHIC 1044
4 GRAPHIC g312302dsp039c.jpg GRAPHIC 912
5 GRAPHIC g312302dsp039d.jpg GRAPHIC 1396
6 GRAPHIC g312302dsp040a.jpg GRAPHIC 1094
7 GRAPHIC g312302dsp040b.jpg GRAPHIC 1081
8 GRAPHIC g312302g84s61.jpg GRAPHIC 26533
  Complete submission text file 0001193125-22-123589.txt   387546
Mailing Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 388-5600
Oric Pharmaceuticals, Inc. (Filer) CIK: 0001796280 (see all company filings)

IRS No.: 471787157 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39269 | Film No.: 22859515
SIC: 2834 Pharmaceutical Preparations